knowledge -WSS

knowledge

author：explore 2025-10-01 18:07:47 - browse：66

TALLINN, Estonia -- A Belarusian journalist was sentenced Friday to four years in prison after being convicted of aiding extremist activities as the authoritarian country continues a severe crackdown on the opposition and independent reporting.

The trial of video journalist Pavel Padabed was held behind closed doors. His conviction and sentencing were reported by the Belarusian Association of Journalists.

Padabed worked with Belsat, a Polish-funded satellite channel that broadcasts into Belarus and is considered by the Belarusian government to be “extremist media.”

The journalists' association said material presented at his trial included investigative programs about the disappearance of a videographer and the 2016 car bombing in Ukraine of TV journalist Pavel Sharemet.

Belarus President Alexander Lukashenko, in power since 1994, has taken an increasingly repressive line toward the opposition and independent journalists since mass protests engulfed the country in 2020 following a presidential election that gave him a sixth term in office but was widely regarded as fraudulent.

The journalists' association says 34 journalists are currently behind bars.

More than 35,000 people were arrested during the 2020 protests, and many were severely beaten by police. The Belarusian human rights group Viasna says there are nearly 1,500 political prisoners in the country.

Exiled opposition leader Sviatlana Tsikhanouskaya, who ran against Lukashenko in 2020, met Friday with European Council President Charles Michel and EU foreign policy chief Josep Borrell.

Afterward, the European Council issued a statement calling on Belarus to stop allowing Russia to base troops there for use in the war in Ukraine and end the deployment there of Russian tactical nuclear weapons.

Previous article： Alkermes shareholders re
Next article： STAT wants to know your pick for a great summer read or listen

WSS

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Doulas covered by Medicaid under New York's new plan

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Stopping antidepressants leads to symptoms for 1 in 6 patients

Risky weight loss products often used by teens globally, per study

explore

knowledge

knowledge

Bright Health sells Medicare Advantage business to Molina

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Alkermes shareholders re

Elevance PBM president out as customers face prescription chaos

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

New Medicare drug pricing powers could soon be upended in court

Peter Hotez and the public health issue of online harassment

Heart disease and mental health: A look at cardiac psychology

Duchenne breakthrough therapy leaves behind pioneering families

DeSantis can now import cheaper drugs. But will Biden get credit?

hotspot

CMS got Medicare Advantage quality rating wrong, judge rules

HHS names first

FDA approves Moderna’s RSV vaccine, its second licensed product

Data don't support strong claims for Covid

CMS got Medicare Advantage quality rating wrong, judge rules

The SUPPORT Act is critical to fighting the opioid crisis

knowledge

focus

explore

knowledge